Page 102 - செவ்வாய் கிரகம் ஆக்ஸிஜந் இல் சிட்டு வள பயன்பாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

(2) CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) Evelo Biosciences (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today announced that it will host a conference call and live webcast at 8:30 a.m. ET on Tuesday, March 9, 2021 to report its fourth quarter and full year 2020 financial results and discuss business highlights. To access the live conference call, please dial 866-795-3242. The archived webcast will be available on Evelo s website approximately two hours after the completion of the event and will be available for 30 days following the call. About Evelo Biosciences Evelo Biosciences is a clinical stage biotechnology company developing orally delivered product candidates that are designed to act on SINTAX with systemic therapeutic effects. SINTAX plays a central role in governing the immune, metabolic, and neurological systems. The Company s first product candidates are pharmaceutical preparations of

United kingdomJessica cotroneEvelo biosciencesKostenloser wertpapierhandelஒன்றுபட்டது கிஂக்டம்ஏவேலோ உயிர் அறிவியல்உயிர் அறிவியல்